Integrated proteogenomic and metabolomic profiling of acute myeloid…
Researchers identified new molecular subtypes in acute myeloid leukemia and pinpointed a drug-resistance driver, opening pathways for more targeted treatment approaches.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
A Neural Network-Enabled, Enzymatic cfDNA Methylation Assay for…
A new blood test can detect colorectal cancer early by analyzing DNA fragments, showing promise for non-invasive screening in larger studies.
Novel or significantly improved treatmentCadonilimab plus chemotherapy as first-line treatment in…
An experimental immune-boosting antibody combined with chemotherapy helped advanced lung cancer patients previously resistant to immunotherapy, with early response prediction.
Underserved or high-risk populationsSocial Determinants of Health in Newly Diagnosed Hereditary…
Analysis reveals stark health disparities for Black and low-income patients with a rare hereditary condition, suggesting concrete targets for improving specialist access.
Near-term implementable findingAssociation of common genetic alterations with tumor recurrence in…
Adding genetic testing to thyroid cancer risk assessment catches high-risk patients missed by standard classification, improving personalized management decisions.